BioSpace News Archive

ORIC Pharmaceuticals, Inc., a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, announced that on August 1, 2023, ORIC granted a total of 28,060 non-qualified stock options and 4,680 restricted stock units to three new non-executive employee who began their employment with ORIC in July 2023.

Syros Pharmaceuticals, a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, announced the grant of restricted stock unit awards for an aggregate of 16,050 shares of Syros common stock to two newly hired employees in connection with commencing employment with Syros.

PacBio announced that PacBio’s Compensation Committee of the Board of Directors granted non-qualified stock options covering an aggregate of 100,000 shares of PacBio common stock and restricted stock units covering 184,700 shares of PacBio common stock to fourteen non-executive employees.

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”), today announced the U.S. Food and Drug Administration (FDA) approved IZERVAY™ (avacincaptad pegol intravitreal solution) for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD) on August 4, 2023.

Sage Therapeutics, Inc., a biopharmaceutical company leading the way to create a world with better brain health, announced that it will host a live webcast on Monday, August 7, 2023 at 8:00 a.m. ET to provide a business update.

Biogen Inc. and Sage Therapeutics, Inc. announced the U.S. Food and Drug Administration approved ZURZUVAE™ 50 mg for adults with postpartum depression.

Sosei Group Corporation provides an update on operational activities and reports its consolidated results for the second quarter and first half ended 30 June 2023.

Duchenne Muscular Dystrophy (DMD) patients showed signs of disease progress slowing down, after oral consumption of Neu REFIX ß-glucan for 45 days along with routine medications.

Zomedica Corp., a veterinary health company offering diagnostic and therapeutic products for companion animals, will host a conference call and audio-only webcast on Thursday, August 10, 2023 at 4:30 p.m. ET to discuss the Company’s operational and financial highlights for its second quarter ending June 30, 2023.

Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II) The shareholders of Biovica International AB, are hereby invited to the annual general meeting to be held on Tuesday 5 September 2023, at 10.00 CET in Conference Hubben’s premises on Dag Hammarskjolds Vag 38 in Uppsala.